Cardiac PET Imaging
Cardiac PET Imaging Overview
MPI Imaging
Available for over 30 years.
Duration of Rest/Stress MPI procedure: 3-4 hours.
Disadvantages include:
Attenuation
Motion artefacts
Processing errors
Limitations in identifying multivessel disease with stress agents
Advancements in Cardiac PET
Initially available exclusively for oncology patients.
Now accessible for cardiac patients.
Advantages of PET technology include:
Improved image quality
Enhanced diagnostic accuracy
Faster acquisition times compared to MPI
Principles of Coincidence Detection
Mechanism of PET:
Positron (β+) emitted from 13N atomic nucleus travels through a medium, losing energy and slowing down.
Interaction occurs with an electron (e−), resulting in annihilation.
Annihilation generates 2 photons traveling 180° apart, each with an energy of 511 keV.
Photons are detected as coincidences in the PET camera's detector ring.
Definition of PET: Positron Emission Tomography.
Normal Myocardial Perfusion Images
Visual quality comparisons of different positron-emitting flow tracers:
13N-ammonia: Excellent image quality.
82Rubidium: Good image quality.
15O-water: Limited visual analysis due to lower count density.
Radiotracers
Ammonia-13 (N-13)
History: Utilized for around 20 years.
Cyclotron required for production.
Half-life: 9.96 minutes.
Behavior in bloodstream:
In the extravascular space, it exists as NH4+.
NH3 is lipid-soluble; crosses membranes into myocytes.
Converted to NH4+ and trapped in association with glutamine.
Disadvantages:
10% lower retention in the lateral wall, resulting in false positives.
Prominent liver activity can obscure inferior wall images.
Rubidium-82 (Rb-82)
Potassium analog, produced by strontium-82 (Sr-82) which has a half-life of 25.5 days.
Rb-82 half-life: 75 seconds; requires onsite generator availability.
Recent regulatory changes allowed reintroduction.
Advantages:
Rapid acquisition times possible; entire protocol completion in 28-30 minutes including stress/rest phases.
Sample PET Procedure
Injection of 55-60 mCi Rb-82.
Gated Rest acquisition lasting approximately 7 minutes.
Vasodilator Stress test lasting about 7 minutes, followed by another injection of Rb-82.
Second gated stress acquisition lasting another 7 minutes.
Indications for Cardiac PET
Who should receive cardiac PET imaging?
Patients with equivocal SPECT stress tests.
Obese patients.
Patients with high suspicion of coronary artery disease (CAD).
Patients with known CAD.
Assessment of myocardial viability.
Evaluation of cardiac sarcoidosis.
Case Evaluations
13N-Ammonia PET/CT and Coronary Angiography
Example of a 62-year-old type 2 diabetic:
Stress images reveal a moderately decreased perfusion defect in lateral, extending to the inferolateral region of the left ventricle, which is reversible in rest images.
Corresponding coronary angiography indicates an occluded marginal branch of the left circumflex artery and stenoses in the proximal left anterior descending artery and mid right coronary artery.
Myocardial Perfusion Study
Example of a 61-year-old patient with arterial hypertension and type 2 diabetes:
Stress images show reduced perfusion defect in mid-to-distal anterior, anteroseptal, and apical regions of the left ventricle, which is reversible at rest.
Uptake preserved in lateral and inferior regions.
Integrated PET/CT images demonstrate accurate coregistration of PET signal with CT-contrast images, allowing for enhanced anatomical mapping.
Viability Assessment
Importance of assessing myocardial viability in patients with Congestive Heart Failure (CHF).
Enhanced understanding of cardiac function correlates with significant morbidity and mortality.
Metabolic considerations:
Normal myocytes rely on fatty acid metabolism.
Damaged myocytes switch to glucose metabolism.
FDG Imaging
Characteristics of Fluorodeoxyglucose (FDG)
FDG is fluorine-labeled 2-deoxyglucose.
Produced through cyclotron.
Half-life: 109.8 minutes.
Positron energy decay: transforms to O-18 (635 keV).
Provides the highest spatial resolution images among commonly used radionuclides.
Metabolic Mechanism
Glucose analog facilitated by glucose-specific transporters into myocytes via diffusion.
When phosphorylated to FDG-6-P, it becomes trapped within the cell.
Viability Evaluation Components
Two main components assessed:
Resting perfusion
Resting metabolism
Presence of viable tissue is indicated by:
Active metabolism with absent perfusion.
Non-viable tissue is characterized by:
Absent perfusion with absent metabolism.
Patients should be stimulated with oral glucose to activate glucose metabolism (glucose loading).